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Abstract
Background: Improper use of antibiotics leads to the emergence of resistant microorganisms as well as drug
toxicity, increased healthcare costs, morbidity and mortality. Globally, an estimated 25–68% of hospitalized patients
receive suboptimal antibiotic regimes. Information on the extent of this problem in Ghana is currently limited,
particularly in surgical units. To strategize for interventions, we estimated the antibiotic use prevalence in surgical
departments in a country-wide point prevalence survey (PPS) in Ghana.
Methods: Between October 2016 and December 2016, we conducted a cross-sectional multi-center country-wide
PPS. This involved an audit of in-patients’ records from all units/departments of ten systematically selected hospitals
in Ghana. Data were collected with a standardized questionnaire, adopted from the European Centre for Disease
Prevention and Control. In this report, we present data on antibiotic use from the surgical units.
Results: Of 2107 eligible patients included in the PPS, 540 patients were identified in surgical units, of which 70.7%
(382/540) received antibiotic therapy. A total of 636 antibiotic prescriptions were issued to these surgical patients;
224 (58.6%) for treatment, including 50 for treatment of hospital-acquired infections, and 144 (37.7%) for prophylaxis
(medical and surgical). Median duration of antibiotic therapy prior to the survey was 5 days (interquartile range
(IQR): 3-8 days). Surgical prophylaxis was administered for longer than the recommended one day in 107 of 144
(88.4%) patients. The choice of antibiotics was largely similar for community- and hospital-acquired infections as
well as for prophylaxis. Only 3.7% of patients had microbiological analysis done on clinical samples.
Conclusion: We found a high prevalence of antibiotic use, with the choice of antibiotics, in some cases,
inconsistent with the country’s treatment guidelines. Antibiotics were administered for long duration including
antibiotics for prophylactic purposes and the majority was started without supporting microbiological analysis.
Prescription practices that encourage rational use of antibiotics guided by microbiology and enforcement of
antibiotic policy guidelines should be the target for future interventions.
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Background
Correct use of antimicrobials, including antibiotics, can
be defined as “the cost-effective use of antimicrobials
which maximizes clinical therapeutic effect, while min-
imizing both drug-related toxicity and the development
of antimicrobial resistance” [1]. A recent systematic re-
view unambiguously concluded that “interventions to
improve antibiotic prescribing to hospital inpatients” are
effective in reducing usage without increasing mortality
and with resulting reduction in length-of-stay and
healthcare costs [2]. However, this was almost entirely
based on studies from North America and Europe and
not a single study from Africa was included. Another re-
view, focusing on low- and middle-income countries
(LMIC), identified this field as a major research priority
to provide tools to curb the spread of antibiotic resist-
ance [3]. In LMIC the situation is further complicated
by the fact that lack of access to relevant antibiotics can
co-exist with excessive and inappropriate use [4]. Thus,
research from high-income countries is of limited value
to guide tailoring of antibiotic stewardship programs in
African countries.
It is generally thought that inappropriate use of anti-
microbials in healthcare facilities is widespread in LMIC
but there are relatively few studies in limited geograph-
ical areas to document this. Generally, antimicrobial pre-
scribing in hospitals, is said to be suboptimal in 25–68%
of cases [3, 5, 6], and in an Australian study, 47% of anti-
biotic use was found to be discordant with guidelines or
microbiological results [7]. Some reasons ascribed to in-
appropriate antibiotic use include lack of regulation in
antibiotic use, high rate of self-medication and lack of
treatment compliance as well as lack of access to appro-
priate and accurate diagnostic facilities [8]. Prescribers’
limited knowledge regarding optimal diagnostic ap-
proaches, lack of resources and opportunity for patient
follow-up and monitoring, lack of experience and diag-
nostic uncertainty also lead to increasing episodes of
prescribing errors [9, 10].
The present study aims to estimate the prevalence of
antibiotic use in surgical departments at all levels of the
healthcare system in Ghana and examine its variation
according to patient-related and care-related charac-
teristics. The prevalence of multidrug resistant bac-
teria is widespread in Ghana, higher in the regional
hospitals than in the teaching hospitals [11], and a re-
cent study has demonstrated the need for actions
aimed at improving antibiotic use [12]. Most litera-
ture on antibiotic prescribing practices in surgical
units in Africa focuses on surgical prophylaxis and
there is a need for comprehensive data on antibiotic
use in these settings. Such data are essential to design
antibiotic stewardship programs, in Ghana and similar
middle-income countries.
Methods
Study design
We analyzed a recent cross-sectional multi-center
country-wide point prevalence study (PPS) of hospital
acquired infections conducted at selected hospitals
under the Ghana Health Service/Ministry of Health be-
tween September and December 2016 [13]. The PPS was
realized through a collaboration between the selected
hospitals and the HAI Ghana project research team, an
international multicenter and interdisciplinary research
network of Ghanaian and Danish experts in the fields of
clinical microbiology, interventional studies, cost ana-
lysis and ethnographic research. Data on antibiotic use
in patients admitted for a surgical specialty were ana-
lyzed for this report.
Overall in Ghana, there are 3 teaching hospitals, 10 re-
gional hospitals and 162 district hospitals in the public
health sector, with a total bed capacity of 12,806 and a
60.4% occupancy rate. District hospitals form the first
referral point from health centers, with a 50–60 bed cap-
acity and facilities for primary clinical care. Regional
hospitals form the secondary level for healthcare, provid-
ing specialized care and with a 150–200 bed capacity.
Tertiary hospitals provide complex tertiary care with
availability of varied surgical specialties, a bed capacity
ranging from 1000 to 2000 [14].
Ten representative hospitals (2 teaching hospitals, 3
regional hospitals and 5 district hospitals), one from
each region, were selected across Ghana using a system-
atic sampling design adopted from the European Centre
for Disease Prevention and Control (ECDC) method-
ology [13, 15]. The total bed capacity of these 10 hospi-
tals was 4208, representing 32.9% of the total bed
capacity for the public hospitals in Ghana.
Patient selection
We included all patients on admission for a surgical spe-
cialty, irrespective of the ward they were admitted on, in
the selected hospitals before 8 a.m. on the day of the sur-
vey and who had not been discharged from the ward at
the time of the survey. We excluded patients admitted
after 8 a.m., patients undergoing same day treatment or
surgery; out-patients including dialysis patients; and pa-
tients in the accident and emergency departments, ex-
cept for wards attached to these departments where
patients are monitored for more than 24 h.
Procedure
The survey was conducted in a single day over a 12-h
period for all hospitals, except for hospitals with large
bed capacity (> 1000), where two or three days were
used. In these large hospitals however, the survey in a
designated department or unit was conducted within a
12-h period, that is 8 a.m. to 8 p.m. on a specified date.
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Five personnel at each survey site, usually members of
the hospital’s quality assurance team or infection control
team, were recruited and trained on the data collection
tool, to join the HAI Ghana research team in data
collection.
Data were collected from available medical and nurs-
ing records using a modified version of the ECDC data
collection tool [15]. From the records we identified pa-
tients on antibiotic therapy on the day of the survey, and
recorded treatment duration for the specified agent and
the results of microbiological analysis if performed.
Patient-based data further included age, sex, surgical dis-
cipline, type of surgery and McCabe score [15].
Statistical analysis
Data was extracted from the multi-center country-wide
study [13] and entered into ACCESS (Microsoft Office
2016) database. Data were cleaned and exported to
STATA / MP version 15.1 for analysis. Statistical analysis
included appropriate descriptive statistics, subpopulation
estimations of percentages, interquartile range and fre-
quencies of patients who had been administered antibi-
otics or not. In all calculations, the subpopulation of 540
surgical patients was analyzed as a random variable of
the 2107 originally sampled patients. In addition, the
two-stage sample design was taken into account by using
the svyset and svy prefix of STATA. The point preva-
lence of antibiotic use was reported as a percentage of
patients on at least one antibiotic over the total number
of patients. Pearson’s chi-square tests, as well as univari-
ate and multivariate logistic regression were used to
demonstrate association of various characteristics. P-
values< 0.05 were considered statistically significant.
Results
Patient characteristics
In total, 540 patients were admitted to surgical units in
the ten selected hospitals surveyed with the following
distribution by hospital category: tertiary 47% (254), re-
gional 18.5% (100) and district 34.4% (186). The median
age was 39 years (range 3 days- 89 years [Interquartile
range (IQR): 20-56 years]) and the male: female ratio
was 1.7:1 Admissions to the general surgical units
accounted for 71.5% (386) of patients, followed by 11.3%
to the orthopedics and trauma units (Table 1). Most pa-
tients, 92% (497), were being managed for non-fatal con-
ditions, 6.3% (34) for ultimately fatal conditions and
1.7% (9) for rapidly fatal conditions. Of all admitted pa-
tients, 48% (261) had undergone a surgical procedure
and 11% (62) had been diagnosed with a healthcare asso-
ciated infection during the current admission (Table 1).
The patients had spent a median of 8 days in hospital
before the survey date, ranging from < 1 to 203 days
(IQR 4 – 18 days). For patients on antibiotic for
treatment, the median duration of stay prior to the sur-
vey was 9 days (range 1 – 142 days, IQR 5–18 days) and
for patients on antibiotic prophylaxis, it was 6 days
(range 0 – 103 days, IQR 3–9 days].
Antibiotic use
Of all the patients, 382 (70.7% (95% CI 63.6–77.9%)) re-
ceived antibiotics, with an average of 1.66 prescriptions
per patient. Among the 382 patients receiving antibi-
otics, 44.2% (169) were on one antibiotic, 46.6% (178) on
two antibiotics, 7.6% (29) on three and 1.6% (6) were on
four antibiotics (Additional file 1:Table S1).
Two major factors significantly affected antibiotic drug
use in the univariate analysis: (1) Surgical procedure
done or not (78.6% vs 63.1%, respectively, p = 0.02) and
(2) Presence of a healthcare associated infection (HAI)
(95.2% vs 67.6 respectively, p = 0.02). Patients admitted
for a urological specialty also had a significantly in-
creased prevalence of antibiotic use (92.3%, p = 0.01). In
contrast, the hospital type, patient age, sex and disease
severity were not associated with antibiotic use (Table 1)
. In the final multivariable analysis, patients who had a
surgical procedure, had an HAI or were managed for a
urological condition, remained significantly more likely
to be prescribed antibiotics (Table 1) – and these factors
were independent of each other with odds ratios similar
to that obtained in univariable analysis.
Antimicrobial agents used
The most frequently prescribed antibiotics across all
levels of facilities were nitroimidazoles (metronidazole)
(25.6% (163 of a total of 636 prescriptions)), 2nd and 3rd
generations cephalosporins (cefuroxime and ceftriaxone
respectively) (20.0% (127)), β-lactam/βlactamase inhibi-
tors (amoxicillin/clavulanic acid) (16.7% (106)), fluoro-
quinolones (ciprofloxacin and levofloxacin) (12.3% (78))
and lincosamides (clindamycin) (10.2% (65)). The differ-
ent antibiotic combinations use by groups is shown in
Additional file 1: Table S1. There were some differences
in the type of antibiotics prescribed between the differ-
ent levels of hospitals (p = 0.002): Penicillins, cephalo-
sporins and carbapenems (meropenem) were used more
in tertiary level facilities (35.7%, p = 0.03; 57.6%, p = 0.01
and 100%, p = 0.01, respectively), whereas β-lactam/ β-
lactamase inhibitors were used more in district hospitals
(40.9%, p = 0.01). The use of nitroimidazoles, fluoroqui-
nolones, lincosamides and penicillins did not differ be-
tween hospital levels (Fig. 1).
The most commonly used antibiotics for treatment of
both community- and hospital-acquired infections were
cephalosporins, amoxicillin-clavulanic acid, clindamycin,
ciprofloxacin and metronidazole (Table 2). The same an-
tibiotics were used for surgical prophylaxis although
Bediako-Bowan et al. BMC Public Health          (2019) 19:797 Page 3 of 10
Table 1 Clinical characteristics and antibiotic use pattern in surgery in hospitals in Ghana
Characteristics Number of
surgical patients
on admissionn
= 540
Number of
surgical
patients on
antibiotics
n = 382
Prevalence (95% CI)
of antibiotic use
amongst surgical
patients
Odds ratio (95% CI)
Univariable analysis
p-
value
Odds ratio (95% CI)
Multivariable analysis
Number of antibiotic
prescriptions n = 636
[Number of prescriptions
/ persons on antibiotic]
Hospital type
District Hospital 186 120 64.5 (56.0–73.1) 1.0 179 [1.49]
Regional
Hospital
100 84 84.0 (68.3–99.7) 2.9 (0.8–9.9) 0.08 166 [1.98]
Tertiary Hospital 254 178 70.1 (64.8–75.3) 1.3 (0.8–2.0) 0.2 291 [1.63]
Surgical specialty
Dental (+ MXF)
Surgery
13 9 69.2 (52.2–86.3) 1.0 19 [2.1]
Ear, Nose and
Throat
8 7 87.5 (50.6–124.4) 3.1 (0.1–95.1) 0.5 10 [1.43]
General Surgery 386 274 71.0 (61.3–80.7) 1.1 (0.4–2.7) 0.8 466 [1.70]
Neurosurgery 24 15 62.5 (62.5–62.5) 0.7 (0.3–1.6) 0.4 26 [1.73]
Ophthalmology 2 0 0.0 – 0 [0.00]
Orthopedics and
trauma
61 40 65.6 (62.1–69.1) 0.8 (0.4–1.9) 0.7 52 [1.30]
Pediatric surgery 33 25 75.8 (67.7–83.8) 1.3 (0.6–3.4) 0.4 42 [1.68]
Urology 13 12 92.3 (92.3–92.3) 5.3 (2.3–11.9) 0.001 5.0 (1.5–15.9) 21 [1.75]
Age group
0–12 (Children) 82 62 75.6 (64.7–86.5) 1.0 111 [1.79]
13–17
(Adolescents)
33 21 63.6 (41.2–86.1) 0.6 (0.2–1.5) 0.2 36 [1.71]
18–29 (Young
adult)
84 58 69.0 (61.6–76.5) 0.7 (0.4–1.4) 0.3 100 [1.72]
30–39 (Thirties) 75 51 68.0 (49.6–86.4) 0.7 (0.4–1.3) 0.2 80 [1.57]
40–64 (Middle
age)
170 121 71.2 (64.0–78.4) 0.8 (0.4–1.5) 0.4 198 [1.64]
> 65 (Old age) 96 69 71.9 (61.7–82.6) 0.8 (0.4–1.9) 0.6 111 [1.61]
Gender
Male 340 243 71.5 (63.1–79.8) 1.0 397 [1.63]
Female 200 139 69.5 (62.1–76.9) 0.9 (0.6–1.3) 0.6 239 [1.72]
McCabe Score
Non-fatal 497 356 71.6 (63.9–79.3) 1.0 594 [1.67]
Rapidly fatal 9 6 66.7 (16.7–116.6) 0.8 (0.1–5.8) 0.8 8 [1.33]
Ultimately fatal 34 20 58.8 (45.6–72.0) 0.6 (0.3–1.2) 0.1 34 [1.70]
Surgical procedure done
No 278 175 63.1 (50.9–75.3) 1.0 293 [1.67]
Yes 262 207 77.6 (72.1–85.0) 2.1 (1.5–3.1) 0.02 2.2 (1.0–4.6) 343 [1.66]
HAI documented
No 478 323 67.6 (59.8–75.4) 1.0 522 [1.62]
Yes 62 59 95.2 (86.8–103.6) 9.4 (1.5–60.3) 0.02 8.9 (1.4–56.5) 114 [1.93]
Types of infections
BSI 4 4 100.0 9 [2.25]
Pneumonia 7 7 100.0 18 [2.57]
SSI 36 33 91.7 (79.5–103.8) 61 [1.85]
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clindamycin and metronidazole were used less for this
indication.
Indication for antibiotic use
Patients were prescribed antibiotics for treatment of in-
fections (58.6% (224/382)) or for prophylaxis (37.7%
(144/382)), and for 14 patients there were no recorded
reason for antibiotic therapy. Of patients prescribed
antibiotics for treatment, 77.7% (174/224) were given for
community acquired infections – including cellulitis,
osteomyelitis, septicemia, urinary tract infections, pyelo-
nephritis, intracerebral abscesses and peritonitis due to
typhoid ileitis with perforation, appendix abscesses and
perforated duodenal ulcers; and 22.3% (50/224) for hos-
pital acquired infections. Of the antibiotics used for
prophylaxis, 16% (23/144) were given for medical
Table 1 Clinical characteristics and antibiotic use pattern in surgery in hospitals in Ghana (Continued)
Characteristics Number of
surgical patients
on admissionn
= 540
Number of
surgical
patients on
antibiotics
n = 382
Prevalence (95% CI)
of antibiotic use
amongst surgical
patients
Odds ratio (95% CI)
Univariable analysis
p-
value
Odds ratio (95% CI)
Multivariable analysis
Number of antibiotic
prescriptions n = 636
[Number of prescriptions
/ persons on antibiotic]
UTI 7 7 100.0 11 [1.57]
Other 8 8 100.0 15 [1.88]
MXF Maxillofacial, McCabe score: Classification of the severity of underlying medical conditions. Non-fatal disease (expected survival at least five years); ultimately
fatal disease (expected survival between one and five years); rapidly fatal disease (expected death within one year); CI Confidence interval, HAI Healthcare
associated infection, BSI Blood stream infection, SSI Surgical site infection, UTI Urinary tract infection
Fig. 1 Antibiotic use in different levels of hospitals. The bars show the percentage of patients on antibiotic therapy. Antibiotics are divided in
main classes, see text for commonly used drugs in each class. *, significant difference in use of the drug class between levels of healthcare
facility (p < 0.05)
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prophylaxis and 84% (121/144) for surgical prophylaxis.
The contribution of surgical prophylaxis to the total anti-
biotic usage was 32% (121 of 382 patients given antibi-
otics). For surgical prophylaxis, 88.4% (107/121) of the
patients received antibiotics for more than one day, 9.9%
(12/121) for one day and 1.6% (2/121) as a single dose.
The distribution between antibiotic use for community-
and hospital-acquired infections and prophylactic use was
similar at district, regional and tertiary facilities (p = 0.7).
Route of administration
Antibiotics were more commonly administered per the
parenteral route (54%) than orally (46%). For individual
antibiotic agents, nitroimidazoles (metronidazole) were
mainly given by the parenteral route (67%), whereas β-
lactam/β-lactamase inhibitors (amoxicillin/clavulanic
acid) were mainly given orally (53%). All 3rd generation
cephalosporins (ceftriaxone) were given parenterally and
2nd generation cephalosporins (cefuroxime) were given
both orally and parenterally (Table 3).
Antibiotic use per source of infection
The most common indications for antibiotic treatment
were infections of the skin, soft tissue, bone and joints
(SSTBJ) (62.5% (140/224)) and gastrointestinal tract
(GIT) (9.8% (22/224)). For prophylaxis, 51.4% (74/144)
Table 2 Indication of antibiotic use in patients of selected hospitals in Ghana
Indication for treatment (n = 382)
Antibiotic group (n) Community acquired
infection (n = 174)
Surgical prophylaxis
(n = 121)
Hospital acquired
infection (n = 53)
Medical prophylaxis
(n = 23)
Unknown indication
(n = 14)
Aminoglycosides (10) 5 0 3 1 1
Penicillin (28) 15 8 4 1 0
Cephalosporins (92) 40 35 9 5 3
Carbapenems (5) 1 1 3 0 0
β-lactam/β-lactamase
inhibitor (88)
31 34 11 7 5
Lincosamides (51) 34 8 6 1 2
Macrolides (1) 0 0 1 0 0
Fluoroquinolones (53) 18 23 8 3 1
Nitroimidazoles (51) 30 11 5 4 1
Nitrofurantoin (2) 0 1 0 0 1
Folate inhibitors (1) 0 0 0 1 0
Table 3 Antibiotic use pattern with respect to route of administration
Route of administration (Number of patients = 382 (%)
Oral n = 176 (46.1%) Parenteral n = 206 (53.9%)
Antibiotic group (n) p-value = 0.002
Aminoglycosides (10) 0 10 (100.0)
Penicillin (28) 10 (35.7) 18 (64.5)
Cephalosporins (92) 41 (44.6) 51 (55.4)
Carbapenems (5) 0 5 (100.0)
β-lactam/β-lactamase inhibitor (88) 46 (52.3) 42 (47.7)
Lincosamides (51) 28 (54.9) 23 (45.1)
Macrolides (1) 1 (50.0) 1 (50.0)
Fluoroquinolones (53) 30 (56.6) 23 (43.4)
Nitroimidazoles (51) 17 (33.3) 34 (66.7)
Nitrofurantoin (2) 2 (100.0) 0
Folate inhibitors (1) 1 (100.0) 0
Duration of antibiotic intake / day
Median (range) 6 (0–89) 4 (1–33)
[IQR] [3–9] [2–7]
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and 25% (36/144) were given to prevent infections of
SSTBJ and GIT infections, respectively. This picture was
similar across hospital levels. Of note, cephalosporins
(cefuroxime), β-lactam/βlactamase inhibitors, clindamy-
cin and metronidazole use dominated treatment of skin,
soft tissue, bone and joint infections whereas fluoro-
quinolone and metronidazole dominated treatment of
gastro-intestinal tract infections (Fig. 2).
Duration of antibiotic use
The median duration of antibiotic therapy prior to the
survey was five days (IQR 3–8 days) with differences
across different hospital levels (p = 0.02). It was 4 days
(range 0-51 days, IQR 2-7 days) in district hospitals, with
a wider range of 1–89 days (median 5 days, IQR: 3–8
days) in tertiary level hospitals.
Depending on the indication, median duration of ther-
apy varied from 6 days (IQR 3–9 days) for hospital
acquired infections to 1 day for surgical prophylaxis
given for one day, (p = 0.001).
In the surgical units, 65 HAIs were identified for 11%
of patients (62/540). Of these, 56% (35/62) were surgical
site infections (35/62) and 95.2% (59/62) were on
antibiotics.
About 4 % (14/382) of patients on antibiotics had
microbiological analysis done on at least one clinical
sample: eight of these in three district hospitals, none of
which had microbiological services, but in such cases
sent samples to private laboratories, and six from one
teaching hospital.
Discussion
This study shows a high prevalence of antibiotic use
(70.7%) among patients admitted to surgical wards
across selected hospitals in Ghana. The study population
represents almost a 1/3 of the hospital capacity in Ghana
Fig. 2 Antibiotic use pattern by organ source of infection. The bars indicate the number of patients being managed with antibiotic for the organ
systems: Skin, soft tissue, bone and joints and Gastrointestinal tract. The other organ sources are omitted since they show no clear patterns of
antibiotic use due to their small numbers
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and is a fair representation of the surgical population
across the country. Although teaching hospitals have a
larger proportion of surgical patients due to their spe-
cialized personnel/ services and their overall bed size
capacity, the results are likely to be representative of the
country as a whole.
Antibiotic use was highest in patients admitted with
urological conditions, and amongst patients who had
undergone a surgical procedure or had developed a
HAI. All the patients admitted with a urologic condition
in this study were from a single tertiary hospital where
there is a long waiting time for patients to see urologists
and a longer time still for those requiring surgeries to
have them done. Such patients may develop recurrent
urinary tract infections requiring antibiotics or if surgery
is performed on the urinary system, have an increased
risk of developing SSIs. This may explain the higher use
of antibiotics. There are low numbers of urologist in the
country and lack of a urology center dedicated to man-
aging such large numbers of patients.
Interestingly, the primary indication for antibiotic use
was treatment of community-acquired infections,
whereas only 1/3 was used for surgical prophylaxis. This
calls into question the usefulness of previous studies in
surgical wards in LMIC that have mostly focused on sur-
gical prophylaxis [16–19].
The rate of antibiotic use in this study is similar to the
70.8% recorded over a decade ago in a teaching hospital
in Ethiopia [20] and higher than the 51% recorded in a
previous study looking at antibiotic use overall in a ter-
tiary facility in Ghana [21]. The prevalence is higher
than what is reported from the United States, 50% [22]
and in acute care hospitals in Europe, 36% [15]. The
high rate of antibiotic use brings to fore the absence of a
national antibiotic use policy at the time of the study
that would guide and control the use of antibiotics in
Ghana [23]. The policy on antimicrobial use and resist-
ance for Ghana [24] and the Ghana national action plan
on antimicrobial resistance [25], both documents
launched in 2018 by the Ministry of Health, Ghana, may
be important to counteract the lack of antimicrobial re-
sistance surveillance for both humans and animals [12].
The new guidelines may address, with their aim to im-
prove infection control, pharmacovigilance and post-
marketing surveillance of medications as well as expand-
ing laboratory testing, the concern of high rates of anti-
biotic consumption demonstrated by this study.
There was a high use of 2nd and 3rd generation ceph-
alosporins in community- and hospital-acquired infec-
tions as well as for medical and surgical prophylaxis.
This goes against the recommendations in the standard
treatment guideline of the Ministry of Health of Ghana
to avoid cephalosporins to help reduce development of
antibiotic resistance in the country [26]. In contrast, the
guidelines recommend the use of penicillins (amoxicillin,
ampicillin or cloxacillin) for community-acquired infec-
tions [26]. It is likely that clinicians wished to safeguard
patients by using broader spectrum antibiotics [27]. In
the absence of microbiological diagnosis, there was no
possibility of scaling down to the appropriate antibiotic
therapy based on results of culture and antibiotic sus-
ceptibility tests [28]. On average, 1.6 antibiotic agents
were administered per patient. In one European study,
1.36 antibiotic agents are prescribed per patient on anti-
biotics [15]. Potentially, the number of antibiotics per
prescription could also be reduced if microbiological
analysis was carried out to find the most appropriate
therapy. Even in the absence of microbiological testing
at the individual level, regular microbiological surveys,
including sensitivity testing, would be useful to inform
treatment guidelines.
In this study, the most commonly used antimicrobials
were metronidazole, cephalosporins, amoxicillin/clavula-
nic acid, fluoroquinolones and clindamycin, and similar
agents were used for antibiotic therapy for community-
and hospital-acquired infections as well as for surgical
prophylaxis. Carbapenems were used at a low rate and
only in tertiary hospitals. Our study design did not allow
for us to directly judge the appropriateness of the choice
of antibiotics. We did, however, notice that half of the
antibiotics given for surgical prophylaxis were nitroimi-
dazole and cefuroxime as recommended in the Ghana
standard treatment guideline for use as surgical anti-
biotic prophylaxis, especially in the instances of colorec-
tal or appendix surgery [26].
Most patients, having spent a median of nine days in
hospital prior to the survey, would have had ample time
for microbiological analysis to be carried out. The low
rate of routine microbiological testing has been attrib-
uted to lack of diagnostic facilities [23, 29]. Regional and
tertiary institutions in Ghana are all equipped with diag-
nostic facilities including the 10 study sites. However,
only half of the study sites had facilities for microbio-
logical analysis. The low rate of microbiological testing
may not only be due to lack of microbiological testing
facilities as seen in this study where district hospitals
that did not have microbiological services used the ser-
vices of private laboratories. Clinicians are key in the
fight against antimicrobial resistance and their education
on the need for microbiological testing whilst prescrib-
ing empirical antibiotics is important. Another reason
for the low rate of microbiological testing may be that
microbiological analyses are not covered by the National
Health Insurance Scheme (NHIS) in Ghana. Thus, the
patients will have to bear these costs [30]. The NHIS in
Ghana, with an almost 40% coverage of the population
[31], would have to review its cost covering policy to
help reduce this low rate of microbiological testing. The
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lack of qualified microbiologists, unstable supplies of
culture media and other essential reagents and equip-
ment, as well as lack of tradition to do cultures may also
account for the low rate of microbiological testing [32].
Previous antimicrobial treatment and excessive duration
of treatment are the two most important factors in the se-
lection of resistant microorganisms [33]. Though this
study did not look at previous use of antibiotics in the ad-
mitted patients, it found that the median duration of ad-
ministration of antibiotics on the survey date, across
selected hospitals was five days, with some antibiotics ad-
ministered for as long as 89 days. Surgical prophylaxis was
generally given for long durations, i.e., more than the one
day that is evidence-based and recommended by the
World Health Organization [34]. Prolonged surgical
prophylaxis does not reduce the number of wound infec-
tions and is rather associated with an increased risk of
antimicrobial resistance and side effects [35].
Our study shows a widespread need for antibiotic stew-
ardship programs, and for qualitative and quantitative
monitoring and evaluation of healthcare professionals’ at-
titudes toward antibiotic use and microbiological testing.
It also suggests the need for improving microbiological
services, to forestall the problem of inadequate antibiotic
use [36–38], with clinical microbiologist playing a key role
in antibiotic stewardship programs. Currently, there is
limited evidence for the effect of antibiotic stewardship
programs in LMIC. Our findings provide a baseline, ur-
gently needed for studies that may provide such evidence.
Limitations
The data were collected based on a review of the health
records, i.e., paper records of patients who were on ad-
mission on the survey day. The district and regional hos-
pitals used similar booklets for everyday recording of
patient management and teaching hospitals used similar
folders. Because there was limited variation in the for-
mat of the records, both types of paper records were
easy to review and deemed reliable for obtaining stand-
ard information on patient management.
The data on antibiotic use were limited, however, by
the fact that this report only looks at the antibiotic use
on the day of the survey and not all the antibiotics used
by patients during the current admission, prior to the
survey date. In addition, all indications were based on
the judgement of the attending clinicians and were not
scrutinized by the research team.
The timing of administration of surgical antibiotic
prophylaxis was not assessed in the study.
The microbiological analysis may be underreported
since only available microbiological reports were reviewed
without respect to those which had been requested or
those done and awaiting results, and this represents an-
other limitation.
Conclusion
There is a high prevalence of antibiotic use in surgical
practice at all levels of hospital care throughout Ghana.
Our study elucidated problems on the appropriate use of
antibiotics, which included long duration of antibiotic
use and limited microbiological testing. For hospitalized
patients there is strong evidence from high income
countries of an effect of antibiotic stewardship programs
on reduction of antibiotic use and resulting benefits at
individual and societal levels. Our findings form the
basis of and strongly call for studies in Ghana aiming at
testing the effects of tailored antibiotic stewardship pro-
grams in LMIC. Policy guidelines on antibiotic use
should be re-emphasized for all stake holders in Ghana.
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patients. A row gives an indication of antibiotics combination for patients
(number of patients on that antibiotic). NB. 169 patients were on 1
antibiotic, 178 patients on 2 antibiotics, 29 patients on 3 antibiotics and 6
patients on 4 antibiotics. (DOCX 18 kb)
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